
Stock Earnings
Monte Rosa Therapeutics Inc (GLUE) receives an Equal weight rating from Wells Fargo
Monte Rosa Therapeutics Inc’s recently made public that its Principal Accounting Officer Dunn Edmund unloaded Company’s shares for reported $9174.0